Clinical Trial: Supplemental Oxygen in Pulmonary Fibrosis

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

Official Title: Observing the Effects of Supplemental Oxygen on Patients With Pulmonary Fibrosis

Brief Summary: To enhance understanding of supplemental oxygen—its utility in and adoption by patients with pulmonary fibrosis—by examining how patients perceive it and by determining how perceptions and patient-centered outcome measures change from before to after supplemental oxygen is prescribed.

Detailed Summary:

The investigators aim to recruit patients with PF to participate in interviews and/or a one-year study of supplemental oxygen (O2). In the one-year study, the investigators will collect data before and for one year after PF patients are prescribed daily-use supplemental oxygen and compare outcomes, including shortness of breath, quality of life, fatigue, cough, and day-to-day functioning before and after O2.

In addition to this, the investigators will interview O2 prescribers and primary supporters/caregivers of PF patients prescribed daily-use O2 to understand the perceptions of others affected by supplemental O2.

Sponsor: National Jewish Health

Current Primary Outcome: Change in dyspnea from immediately prior to one month after starting daily-use supplemental oxygen [ Time Frame: One month post daily-use supplemental oxygen implementation ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

• Change in quality of life, fatigue and cough from prior to one month after daily-use supplemental oxygen implementation [ Time Frame: One month after daily-use supplemental oxygen implementation ]
• Change in day-to-day functioning and activity space from prior to one month after daily-use supplemental oxygen implementation [ Time Frame: One month after daily-use supplemental oxygen implementation ]
  Functioning will be captured by having patients wear an activity monitor, and activity space will be capture by having patients wear a mobile GPS recorder.

Original Secondary Outcome: Same as current

Information By: National Jewish Health

Dates:
Date Received: October 9, 2013
Date Started: October 2013
Date Completion:
Last Updated: May 2, 2017
Last Verified: April 2015